These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8519230

  • 1. [Measurement of prothrombin fragment F1+2 for monitoring the anticoagulant effect of phenprocoumon].
    Bruhn HD, Zurborn KH.
    Dtsch Med Wochenschr; 1993 Jul 02; 118(26):967-70. PubMed ID: 8519230
    [Abstract] [Full Text] [Related]

  • 2. The use of prothrombin fragment F1+2 to monitor the effect of oral anticoagulation.
    Bruhn HD, Zurborn KH.
    J Heart Valve Dis; 1995 Mar 02; 4(2):138-40. PubMed ID: 8556173
    [Abstract] [Full Text] [Related]

  • 3. Effects of the oral anticoagulant phenprocoumon on blood coagulation and thrombogenesis induced by rabbit aorta subendothelium exposed to flowing human blood: role of dose and shear rate.
    Inauen W, Bombeli T, Baumgartner HR, Haeberli A, Straub PW.
    J Lab Clin Med; 1991 Sep 02; 118(3):280-8. PubMed ID: 1919300
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of Quick/INR values of whole capillary blood (CoaguChek Plus) and venous citrate plasma in patients with and without oral anticoagulation].
    Burri S, Demarmels Biasiutti F, Lämmle B, Wuillemin WA.
    Schweiz Med Wochenschr; 1998 Oct 31; 128(44):1723-9. PubMed ID: 9846345
    [Abstract] [Full Text] [Related]

  • 5. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A, Della Valle P, Crippa L, Fattorini A, Pattarini E, Viganò D'Angelo S.
    Haematologica; 2002 Oct 31; 87(10):1074-80. PubMed ID: 12368163
    [Abstract] [Full Text] [Related]

  • 6. Changes of prothrombin fragment 1+2 (F 1+2) as a function of increasing intensity of oral anticoagulation--considerations on the suitability of F 1+2 to monitor oral anticoagulant treatment.
    Tripodi A, Cattaneo M, Molteni A, Cesana BM, Mannucci PM.
    Thromb Haemost; 1998 Mar 31; 79(3):571-3. PubMed ID: 9531043
    [Abstract] [Full Text] [Related]

  • 7. Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.
    Koefoed BG, Feddersen C, Gulløv AL, Petersen P.
    Thromb Haemost; 1997 May 31; 77(5):845-8. PubMed ID: 9184390
    [Abstract] [Full Text] [Related]

  • 8. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
    Joshi A, Magder LS, Kon Z, Kallam S, Kwon M, Sangrampurkar R, Pierson R, Poston R.
    Interact Cardiovasc Thorac Surg; 2007 Jun 31; 6(3):323-7. PubMed ID: 17669856
    [Abstract] [Full Text] [Related]

  • 9. Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism.
    Kyrle PA, Stümpflen A, Hirschl M, Bialonczyk C, Herkner K, Speiser W, Weltermann A, Kaider A, Pabinger I, Lechner K, Eichinger S.
    Thromb Haemost; 1997 Nov 31; 78(5):1327-31. PubMed ID: 9408013
    [Abstract] [Full Text] [Related]

  • 10. Effect of different oral anticoagulant intensities on prothrombin fragment 1 + 2 in Thai patients with mechanical heart valve prostheses.
    Tientadakul P, Opartkiattikul N, Sangtawesin W, Sakiyalak P.
    J Med Assoc Thai; 1997 Feb 31; 80(2):81-6. PubMed ID: 9078691
    [Abstract] [Full Text] [Related]

  • 11. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S, Morstabilini G, Fattorini A, Galli L, Denti N, D'Angelo A.
    Haematologica; 2002 Dec 31; 87(12):1265-73. PubMed ID: 12495900
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of plasma prothrombin fragment 1+2 in healthy donors and thrombotic diseases].
    Kawai Y, Shiomi T, Ono H, Katagiri H, Uchida R, Sugisaki N, Watanabe K.
    Rinsho Byori; 1994 Jan 31; 42(1):57-62. PubMed ID: 8107284
    [Abstract] [Full Text] [Related]

  • 13. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P, Crippa L, Garlando AM, Pattarini E, Safa O, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Dec 31; 84(12):1065-74. PubMed ID: 10586206
    [Abstract] [Full Text] [Related]

  • 14. Multicentric evaluation of a new assay for prothrombin fragment F1+2 determination.
    Bruhn HD, Conard J, Mannucci M, Monteagudo J, Pelzer H, Reverter JC, Samama M, Tripodi A, Wagner C.
    Thromb Haemost; 1992 Oct 05; 68(4):413-7. PubMed ID: 1448772
    [Abstract] [Full Text] [Related]

  • 15. [Value of molecular markers for administration of anticoagulant therapy after heart valve replacement].
    Dahm M, Lotz J, Hafner G, Oelert H, Prellwitz W.
    Z Kardiol; 1998 Oct 05; 87 Suppl 4():42-5. PubMed ID: 9857466
    [Abstract] [Full Text] [Related]

  • 16. INR comparison between the CoaguChek Pro PT(N) and a standard laboratory method.
    Khoschnewis S, Hannes FM, Tschopp M, Wuillemin WA.
    Thromb Res; 2004 Oct 05; 113(5):327-32. PubMed ID: 15183045
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of hypercoagulable state in patients with malignancies by using prothrombin fragment F1 + 2].
    Nakagawa K, Tsuji H, Yamada K, Yamada Y, Masuda H, Yamagami M, Yoneda M, Takada O, Sawada S, Kitani T.
    Rinsho Ketsueki; 1992 Nov 05; 33(11):1666-72. PubMed ID: 1469781
    [Abstract] [Full Text] [Related]

  • 18. [Changes in antithrombin III, prothrombin fragment 1 + 2 and thrombin-antithrombin III complex following implantation of a coronary Palmaz-Schatz stent].
    Dittel M, Haushofer A, Spiel R, Halbmayer WM, Prachar H, Fischer M, Mlczoch J.
    Z Kardiol; 1995 Jan 05; 84(1):22-9. PubMed ID: 7863710
    [Abstract] [Full Text] [Related]

  • 19. Course of thrombin activation markers in patients implanted with Palmaz-Schatz stents: first experiences with a post-interventional anticoagulation regimen.
    Haushofer A, Halbmayer WM, Dittel M, Prachar H, Mlczoch J, Fischer M.
    Blood Coagul Fibrinolysis; 1994 Oct 05; 5(5):697-706. PubMed ID: 7865675
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.